Safety and Efficacy of Genakumab for Injection in Patients With Gout Initiating Urico-lowering Therapy
Conditions: Acute Gout; Gout Initiating Urico-lowering Therapy Interventions: Drug: Genakumab for injection; Drug: Etoricorxib Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Conditions: Acute Gout; Gout Flare Interventions: Drug: Genakumab for injection; Drug: Colchicine Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Initiating Urico-lowering Therapy
Conditions: Acute Gout; Gout Initiating Urico-lowering Therapy Interventions: Drug: Genakumab for injection; Drug: Etoricorxib Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Conditions: Acute Gout; Gout Flare Interventions: Drug: Genakumab for injection; Drug: Colchicine Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Initiating Urico-lowering Therapy
Conditions: Acute Gout; Gout Initiating Urico-lowering Therapy Interventions: Drug: Genakumab for injection; Drug: Etoricorxib Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Conditions: Acute Gout; Gout Flare Interventions: Drug: Genakumab for injection; Drug: Colchicine Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Initiating Urico-lowering Therapy
Conditions: Acute Gout; Gout Initiating Urico-lowering Therapy Interventions: Drug: Genakumab for injection; Drug: Etoricorxib Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Conditions: Acute Gout; Gout Flare Interventions: Drug: Genakumab for injection; Drug: Colchicine Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Initiating Urico-lowering Therapy
Conditions: Acute Gout; Gout Initiating Urico-lowering Therapy Interventions: Drug: Genakumab for injection; Drug: Etoricorxib Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
Conditions: Acute Gout; Gout Flare Interventions: Drug: Genakumab for injection; Drug: Colchicine Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2023 Category: Research Source Type: clinical trials
Assessment of Physician Consideration of ePRO's, From Patients With Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Conditions: Gout; Rheumatoid Arthritis; Sjogren's Syndrome; Systemic Lupus Erythematosus Intervention: Behavioral: Therapeutic management following access by the physician to his patient's ePROs Sponsor: University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials
